Home › Prostate Cancer › Missouri
Prostate Cancer clinical trials in Missouri
48 studies for Prostate Cancer are looking for participants at sites in Missouri.
Cities in Missouri
- St. Louis47 studies
- Kansas City14 studies
- O'Fallon9 studies
- Cape Girardeau7 studies
- Rolla5 studies
- Saint Joseph4 studies
- Lee's Summit4 studies
- Springfield4 studies
- Joplin3 studies
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
- Saint Francis Medical Center, Cape Girardeau
- Siteman Cancer Center at Saint Peters Hospital, City of Saint Peters
- Siteman Cancer Center at West County Hospital, Creve Coeur
- and 11 more
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 29, 2026 · NCT03866382Impact of Fluciclovine (18F) PET (Positron Emission Tomography) on the Management of Prostate Cancer Following Negative or Equivocal PSMA (Prostate-Specific Membrane Antigen) PET Imaging at the Time of Biochemical Recurrence
- Washington University, St Louis
RecruitingPhase 4
Ages 18 and older · Men · Updated Sep 29, 2026 · NCT07569926A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
- Washington University, School of Medicine, St Louis
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 25, 2026 · NCT06172478Open-label Study Comparing AAA817 Versus Standard of Care in the Treatment of Previously Treated PSMA-positive mCRPC Adults Who Have Disease Progressed on or After [177Lu]Lu-PSMA Targeted Therapy
- WA Uni School Of Med, St Louis
RecruitingPhase 2/3
Ages 18 to 100 · Men · Updated Sep 22, 2026 · NCT06780670Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC
- Wash U School of Medicine, St Louis
RecruitingPhase 3
Ages 18 to 100 · Men · Updated Sep 22, 2026 · NCT06855277A Study of LY4257496 in Participants With Cancer (OMNIRAY)
- Washington University, St Louis
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 22, 2026 · NCT07114601Carboplatin or Olaparib for BRcA Deficient Prostate Cancer
- Kansas City VA Medical Center, Kansas City, MO, Kansas City
RecruitingPhase 2
Ages 18 and older · Men · Updated Sep 17, 2026 · NCT04038502High Dose Testosterone for ATM, CDK12 or CHEK2 Altered Prostate Cancers
- Kansas City VA Medical Center, Kansas City, MO, Kansas City
- St. Louis VA Medical Center John Cochran Division, St. Louis, MO, St Louis
RecruitingPhase 2
Ages 18 and older · Men · Updated Sep 17, 2026 · NCT05011383Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
- Saint Francis Medical Center, Cape Girardeau
- Siteman Cancer Center at Saint Peters Hospital, City of Saint Peters
- Siteman Cancer Center at West County Hospital, Creve Coeur
- and 10 more
RecruitingPhase 3
Ages 18 and older · Men · Updated Sep 10, 2026 · NCT05946213Daily Adaptive Radiation Therapy Using an Individualized Approach for Prostate Cancer
- Washington University in St. Louis, St Louis
Recruiting
Ages 18 and older · Men · Updated Sep 9, 2026 · NCT05804318A Study to Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid Tumors
- Washington University School of Medicine, St Louis
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 9, 2026 · NCT06440005A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
- Washington University School of Medicine in St. Louis, St Louis
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 4, 2026 · NCT06465069Study of JANX014 in Subjects With Metastatic Castration-Resistant Prostate Cancer
- Washington University School of Medicine, St Louis
RecruitingPhase 1
Ages 18 and older · Men · Updated Sep 3, 2026 · NCT07545811Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial
- Saint Francis Medical Center, Cape Girardeau
- Siteman Cancer Center at Saint Peters Hospital, City of Saint Peters
- Siteman Cancer Center at West County Hospital, Creve Coeur
- and 10 more
RecruitingPhase 3
Ages 18 and older · Men · Updated Sep 2, 2026 · NCT06931340Testing Different Dosing Schedules of the Anti-cancer Drug, Lutetium 177Lu PSMA RLT and Its Effect on Patients With Advanced Prostate Cancer, RECIPROCAL Trial
- Heartland Regional Medical Center, Saint Joseph
- Missouri Baptist Medical Center, St Louis
RecruitingPhase 3
Ages 18 and older · Men · Updated Sep 2, 2026 · NCT07200830Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- Mercy Oncology and Hematology - Clayton-Clarkson, Ballwin
- Central Care Cancer Center - Bolivar, Bolivar
- Cox Cancer Center Branson, Branson
- and 21 more
RecruitingObservational studyHealthy volunteers welcome
Ages 40 to 75 · All sexes · Updated Sep 2, 2026 · NCT05334069The Vanguard Study: Testing a New Way to Screen for Cancer
- Saint Luke's Hospital of Kansas City, Kansas City
- Washington University School of Medicine, St Louis
RecruitingHealthy volunteers welcome
Ages 45 to 75 · All sexes · Updated Sep 2, 2026 · NCT06995898Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial
- Siteman Cancer Center at Saint Peters Hospital, City of Saint Peters
- Siteman Cancer Center at West County Hospital, Creve Coeur
- Washington University School of Medicine, St Louis
- and 2 more
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 2, 2026 · NCT06632977AZD2265 Compared With Standard of Care in PSMA-positive Metastatic Castration-resistant Prostate Cancer (VECTRA-01)
- Research Site, St Louis
RecruitingPhase 3
Ages 18 and older · Men · Updated Aug 26, 2026 · NCT07611110A Single-Arm Phase II Study of Neoadjuvant Intensified Androgen Deprivation (Leuprolide and Abiraterone Acetate) in Combination With AKT Inhibition (Capivasertib) for High-Risk Localized Prostate Cancer With PTEN Loss
- St. Louis VA Medical Center John Cochran Division, St. Louis, MO, St Louis
RecruitingPhase 2
Ages 18 and older · Men · Updated Aug 25, 2026 · NCT05593497Study of AMG 509 in Participants With Metastatic Castration-Resistant Prostate Cancer
- Washington University, St Louis
RecruitingPhase 1
Ages 18 and older · Men · Updated Aug 21, 2026 · NCT04221542A Phase 1b/2a Study of Pocenbrodib as Monotherapy and in Combination With Darolutamide in Participants With mCRPC
- Siteman Cancer Center, St Louis
RecruitingPhase 1/2
Ages 18 and older · Men · Updated Aug 20, 2026 · NCT06785636Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
- Central Care Cancer Center - Bolivar, Bolivar
- Mercy Cancer Center - Cape Girardeau, Cape Girardeau
- Saint Francis Medical Center, Cape Girardeau
- and 19 more
RecruitingPhase 3
Ages 18 and older · Men · Updated Aug 19, 2026 · NCT04423211Impact of an Electronic Health Record Maintenance Alert on PSA Screening Rates in a 10-Hospital Integrated Health System
- Washington University School of Medicine, St Louis
RecruitingHealthy volunteers welcome
Ages 40 to 75 · Men · Updated Aug 19, 2026 · NCT07109427FOG-001 in Locally Advanced or Metastatic Solid Tumors
- Washington University School of Medicine, St Louis
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Aug 17, 2026 · NCT05919264Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01)
- Washington University School of Medicine, St Louis
RecruitingPhase 1
Ages 18 to 100 · Men · Updated Aug 13, 2026 · NCT05519449A Trial to Learn How Safe AZD9750 is and How Well it Works in People With Metastatic Prostate Cancer When Given With or Without Other Anticancer Drugs
- Research Site, St Louis
RecruitingPhase 1/2
Ages 18 and older · Men · Updated Aug 10, 2026 · NCT07336446IDOV-Immune for Advanced Solid Tumors
- Washington University School of Medicine, St Louis
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Aug 5, 2026 · NCT06910657Evaluation of Neoadjuvant Xaluritamig in Localized Prostate Cancer
- Washington University, St Louis
RecruitingPhase 1
Ages 18 and older · Men · Updated Jul 31, 2026 · NCT06613100Study of Orally Administered MOMA-313 in Participants With Advanced or Metastatic Solid Tumors
- Investigative Site #110, St Louis
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Jul 23, 2026 · NCT06545942PSMA PET Combined With MRI for the Detection of PCa
- Washington University, St Louis
RecruitingPhase 3Healthy volunteers welcome
Ages 18 and older · Men · Updated Jul 23, 2026 · NCT07052214Low-Count Quantitative SPECT for Men Treated With Radium-223
- Washington University School of Medicine, St Louis
Recruiting
Ages 18 and older · Men · Updated Jul 21, 2026 · NCT07221825Diffusion Basis Spectrum Imaging of the Prostate
- Washington University School of Medicine, St Louis
Recruiting
Ages 18 and older · Men · Updated Jul 14, 2026 · NCT04420702Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
- Siteman Cancer Center at Saint Peters Hospital, City of Saint Peters
- Siteman Cancer Center at West County Hospital, Creve Coeur
- Washington University School of Medicine, St Louis
- and 2 more
RecruitingPhase 3
Ages 18 and older · Men · Updated Jul 14, 2026 · NCT06592924CARE Tool Study Aim 3
- Delbert Day Cancer Institute at Phelps Health, Rolla
- Washington University School of Medicine, St Louis
Recruiting
Ages 18 and older · All sexes · Updated Jul 8, 2026 · NCT07296887Integrated Cancer Repository for Cancer Research
- Saint Luke's Cancer Institute, East, Kansas City
- Saint Luke's Cancer Institute, Kansas City
- Saint Luke's Cancer Institute, Kansas City North, Kansas City
- and 3 more
RecruitingObservational studyHealthy volunteers welcome
Ages 19 to 110 · All sexes · Updated Jun 29, 2026 · NCT02012699Postoperative or Salvage Radiotherapy (RT) for Node Negative Prostate Cancer Following Radical Prostatectomy
- Mercy David C. Pratt Cancer Center, St Louis
Recruiting
Ages 18 and older · Men · Updated Jun 17, 2026 · NCT00969111Abiraterone, Enzalutamide, or Apalutamide in Castrate-sensitive Prostate Cancer.
- VA St. Louis Health Care System, St Louis
RecruitingPhase 2
Ages 18 and older · Men · Updated Jun 15, 2026 · NCT05422911Long-Term Safety of Lutetium (177Lu) Vipivotide Tetraxetan in Participants With Prostate Cancer
- Wash U School of Medicine, St Louis
RecruitingPhase 4
Ages 18 to 100 · Men · Updated Jun 4, 2026 · NCT05803941Neoadjuvant Atezolizumab-Based Combination Therapy in Men With Localized Prostate Cancer Prior to Radical Prostatectomy
- Alvin J. Siteman Cancer Center at Washington University, St Louis
RecruitingPhase 2
Ages 18 and older · Men · Updated Jun 4, 2026 · NCT03821246From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.